JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage … Read more
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.095x
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹3.62 Billion) by net assets (₹38.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Photronics Inc
NASDAQ:PLAB
|
0.059x |
|
Joulwatt Technology Co. Ltd. A
SHG:688141
|
-0.026x |
|
Reliance Worldwide Corporation Limited
PINK:RLLWF
|
0.063x |
|
ePlus inc
NASDAQ:PLUS
|
-0.082x |
|
Disc Medicine Inc.
NASDAQ:IRON
|
-0.083x |
|
Changzhou Fusion New Material Co. Ltd. A
SHG:688503
|
N/A |
|
Dynex Capital Inc
NYSE:DX
|
0.035x |
|
Aecc Aero Engine Control Co Ltd
SHE:000738
|
-0.025x |
Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹34.33 Billion | ₹9.02 Billion | 0.263x | -4.02% |
| 2024-03-31 | ₹29.23 Billion | ₹8.01 Billion | 0.274x | +8.58% |
| 2023-03-31 | ₹24.80 Billion | ₹6.26 Billion | 0.252x | +217.05% |
| 2022-03-31 | ₹21.39 Billion | ₹1.70 Billion | 0.080x | -54.17% |
| 2021-03-31 | ₹18.13 Billion | ₹3.15 Billion | 0.174x | -9.35% |
| 2020-03-31 | ₹14.38 Billion | ₹2.75 Billion | 0.191x | +47.08% |
| 2019-03-31 | ₹14.83 Billion | ₹1.93 Billion | 0.130x | +52.83% |
| 2018-03-31 | ₹14.44 Billion | ₹1.23 Billion | 0.085x | -41.88% |
| 2017-03-31 | ₹13.66 Billion | ₹2.00 Billion | 0.147x | +14.95% |
| 2016-03-31 | ₹10.95 Billion | ₹1.40 Billion | 0.128x | +0.15% |
| 2015-03-31 | ₹9.95 Billion | ₹1.27 Billion | 0.127x | +1049.86% |
| 2014-03-31 | ₹10.43 Billion | ₹-139.78 Million | -0.013x | -116.10% |
| 2013-03-31 | ₹10.20 Billion | ₹849.32 Million | 0.083x | -90.82% |
| 2012-03-31 | ₹9.70 Billion | ₹8.80 Billion | 0.907x | +368.67% |
| 2011-03-31 | ₹6.92 Billion | ₹1.34 Billion | 0.194x | -9.87% |
| 2010-03-31 | ₹5.68 Billion | ₹1.22 Billion | 0.215x | +10.50% |
| 2009-03-31 | ₹4.69 Billion | ₹911.05 Million | 0.194x | +210.91% |
| 2008-03-31 | ₹4.53 Billion | ₹283.11 Million | 0.062x | +17.36% |
| 2007-03-31 | ₹4.18 Billion | ₹222.82 Million | 0.053x | -21.99% |
| 2006-03-31 | ₹3.30 Billion | ₹225.51 Million | 0.068x | -- |